Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-06-30 View official record Methodology

Covered recipient · General Payments record

KENNETH E ROBERTS

Allopathic & Osteopathic Physicians Family Medicine

NPI
1598732521
CMS profile
693603
Location
OZARK, AL

General Payments · PY2019–2025

$3,466.09

  • Reported across 194 records
  • CMS publication 2026-06-30

Latest program year · PY2025

$276.04

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2025 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $257.19 14
Education $18.85 1

By paying entity

PY2025 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $309.16 15
PY2020 $434.15 29
PY2021 $420.43 29
PY2022 $724.97 38
PY2023 $619.36 38
PY2024 $681.98 30
PY2025 $276.04 15

Payment records · PY2025 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2025 201920202021202220232024 Record-level detail is published for PY2025; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Alkermes, Inc. $18.65 08/21/2025 Food and Beverage Undisputed 06/30/2026 1222624749 CMS
AstraZeneca Pharmaceuticals LP $17.52 01/24/2025 Food and Beverage Undisputed 06/30/2026 1206483343 CMS
AstraZeneca Pharmaceuticals LP $13.84 03/27/2025 Food and Beverage Undisputed 06/30/2026 1206819157 CMS
AstraZeneca Pharmaceuticals LP $24.01 05/16/2025 Food and Beverage Undisputed 06/30/2026 1206260582 CMS
AstraZeneca Pharmaceuticals LP $19.94 08/29/2025 Food and Beverage Undisputed 06/30/2026 1206181610 CMS
AstraZeneca Pharmaceuticals LP $16.24 10/24/2025 Food and Beverage Undisputed 06/30/2026 1206734439 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $18.85 03/18/2025 Education Undisputed 06/30/2026 1222882607 CMS
GlaxoSmithKline, LLC. $20.26 01/29/2025 Food and Beverage Undisputed 06/30/2026 1190411793 CMS
GlaxoSmithKline, LLC. $20.65 03/27/2025 Food and Beverage Undisputed 06/30/2026 1190561716 CMS
GlaxoSmithKline, LLC. $20.13 08/20/2025 Food and Beverage Undisputed 06/30/2026 1190411843 CMS
Merck Sharp & Dohme LLC $22.23 01/03/2025 Food and Beverage Undisputed 06/30/2026 1238082739 CMS
Merck Sharp & Dohme LLC $14.61 03/07/2025 Food and Beverage Undisputed 06/30/2026 1238015841 CMS
Merck Sharp & Dohme LLC $15.44 04/18/2025 Food and Beverage Undisputed 06/30/2026 1238352878 CMS
Merck Sharp & Dohme LLC $15.44 05/30/2025 Food and Beverage Undisputed 06/30/2026 1238126855 CMS
Merck Sharp & Dohme LLC $18.23 06/27/2025 Food and Beverage Undisputed 06/30/2026 1238072666 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.